Insufficient scRNA-seq data for expression of SHOX2 at single-cell level.
Insufficient scRNA-seq data for expression of SHOX2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 1000.61 | 457 / 459 | 91% | 3.78 | 1022 / 1118 |
| skin | 86% | 776.47 | 1553 / 1809 | 83% | 4.95 | 391 / 472 |
| uterus | 30% | 164.86 | 51 / 170 | 73% | 5.82 | 335 / 459 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 6.09 | 41 / 45 |
| blood vessel | 84% | 1177.50 | 1125 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 15% | 53.19 | 221 / 1445 | 49% | 2.29 | 90 / 183 |
| lymph node | 0% | 0 | 0 / 0 | 62% | 1.37 | 18 / 29 |
| adipose | 58% | 879.42 | 704 / 1204 | 0% | 0 | 0 / 0 |
| lung | 3% | 7.04 | 17 / 578 | 53% | 3.37 | 616 / 1155 |
| pancreas | 1% | 1.61 | 2 / 328 | 43% | 1.26 | 76 / 178 |
| adrenal gland | 0% | 0 | 0 / 258 | 43% | 5.48 | 99 / 230 |
| heart | 42% | 232.59 | 359 / 861 | 0% | 0 | 0 / 0 |
| brain | 1% | 7.16 | 25 / 2642 | 38% | 4.69 | 271 / 705 |
| bladder | 10% | 16.86 | 2 / 21 | 30% | 1.67 | 149 / 504 |
| muscle | 35% | 94.78 | 285 / 803 | 0% | 0 | 0 / 0 |
| thymus | 21% | 66.38 | 138 / 653 | 8% | 0.15 | 46 / 605 |
| ovary | 3% | 7.53 | 6 / 180 | 18% | 0.67 | 78 / 430 |
| stomach | 3% | 9.28 | 9 / 359 | 16% | 0.58 | 45 / 286 |
| intestine | 0% | 0.76 | 4 / 966 | 13% | 0.49 | 71 / 527 |
| peripheral blood | 9% | 55.53 | 84 / 929 | 0% | 0 | 0 / 0 |
| prostate | 3% | 9.93 | 8 / 245 | 4% | 0.11 | 19 / 502 |
| kidney | 0% | 0 | 0 / 89 | 6% | 0.32 | 55 / 901 |
| liver | 0% | 0 | 0 / 226 | 5% | 0.22 | 21 / 406 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007224 | Biological process | smoothened signaling pathway |
| GO_0050772 | Biological process | positive regulation of axonogenesis |
| GO_0060415 | Biological process | muscle tissue morphogenesis |
| GO_0001649 | Biological process | osteoblast differentiation |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_2000648 | Biological process | positive regulation of stem cell proliferation |
| GO_0002027 | Biological process | regulation of heart rate |
| GO_0072089 | Biological process | stem cell proliferation |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0060931 | Biological process | sinoatrial node cell development |
| GO_0035115 | Biological process | embryonic forelimb morphogenesis |
| GO_2000172 | Biological process | regulation of branching morphogenesis of a nerve |
| GO_0060272 | Biological process | embryonic skeletal joint morphogenesis |
| GO_0002063 | Biological process | chondrocyte development |
| GO_0045880 | Biological process | positive regulation of smoothened signaling pathway |
| GO_0002053 | Biological process | positive regulation of mesenchymal cell proliferation |
| GO_0048557 | Biological process | embryonic digestive tract morphogenesis |
| GO_0010463 | Biological process | mesenchymal cell proliferation |
| GO_0003172 | Biological process | sinoatrial valve development |
| GO_0003213 | Biological process | cardiac right atrium morphogenesis |
| GO_0003163 | Biological process | sinoatrial node development |
| GO_0001501 | Biological process | skeletal system development |
| GO_0007399 | Biological process | nervous system development |
| GO_0060920 | Biological process | cardiac pacemaker cell differentiation |
| GO_0032330 | Biological process | regulation of chondrocyte differentiation |
| GO_0060351 | Biological process | cartilage development involved in endochondral bone morphogenesis |
| GO_0048743 | Biological process | positive regulation of skeletal muscle fiber development |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| Gene name | SHOX2 |
| Protein name | Short stature homeobox protein 2 (Homeobox protein Og12X) (Paired-related homeobox protein SHOT) Short stature homeobox 2 |
| Synonyms | SHOT OG12X |
| Description | FUNCTION: May be a growth regulator and have a role in specifying neural systems involved in processing somatosensory information, as well as in face and body structure formation. |
| Accessions | O60902 ENST00000554685.2 A0A087WVB7 ENST00000441443.6 [O60902-1] ENST00000389589.8 [O60902-3] ENST00000483851.7 [O60902-2] |